本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Oric Pharmaceuticals Inc.

10.23
-0.2600-2.48%
盘后10.230.00000.00%19:49 EDT
成交量:79.43万
成交额:831.97万
市值:8.72亿
市盈率:-5.44
高:10.87
开:10.32
低:10.20
收:10.49
数据加载中...
2024/08/12

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/12

重要事件披露

Form 8-K - Current report
2024/06/14

重要事件披露

Form 8-K - Current report
2024/05/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/06

重要事件披露

Form 8-K - Current report
2024/03/29

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/29

重要事件披露

Form 8-K - Current report
2024/03/11

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/11

重要事件披露

Form 8-K - Current report
2024/03/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/06

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/01

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/01

SEC问询函

Form CORRESP - Correspondence
2024/01/30

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/26

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/22

重要事件披露

Form 8-K - Current report